Is Raphael Pharmaceutical Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Raphael Pharmaceutical Inc (RAPH) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Raphael Pharmaceutical Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Raphael Pharmaceutical Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Raphael Pharmaceutical Inc?

Muslim investors may consider investing in Raphael Pharmaceutical Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Raphael Pharmaceutical Inc classified as NOT COVERED?

Musaffa determines the Shariah status of Raphael Pharmaceutical Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Raphael Pharmaceutical Inc updated?

The Shariah compliance status of Raphael Pharmaceutical Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Raphael Pharmaceutical Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Raphael Pharmaceutical Inc?

You can check the latest Shariah compliance status of Raphael Pharmaceutical Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Raphael Pharmaceutical Inc. Stock Analysis RAPH

United States N/A Nano Cap

Raphael Pharmaceutical, Inc. is a clinical-stage biotechnology company. The firm is focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol (CBD) oil. The firm has completed the study for its lead product candidate for the treatment of rheumatoid arthritis (RA), and is developing asthma product candidates, which are in the pre-clinical-stage. The firm is also continuing to investigate its product for the treatment of autoimmune diseases. The Company’s discovery platform focuses on the use of CBD oil, one of the cannabinoids in cannabis plants, as the active pharmaceutical ingredient (API), for its RA product candidate and COVID-19 product candidate.

Key Statistics of Raphael Pharmaceutical Inc (RAPH)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.40$1.40

Today's Open

$1.40

Volume

100.00

P/E Ratio (TTM)

52 Week Range

$0.04$1.40

Market Cap

28.25M

Avg. Volume

180.00

Dividend Yield

Financial Metrics & Statements of Raphael Pharmaceutical Inc (RAPH)

FAQ's for Raphael Pharmaceutical Inc (RAPH)

According to Musaffa’s Shariah screening methodology, Raphael Pharmaceutical Inc (RAPH) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.